Beam Therapeutics GAAP EPS of -$0.91 beats by $0.11, revenue of $31.74M beats by $19.52M
Beam Therapeutics Inc. Common Stock · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $31.14
-15% in 7d after detection
Post-detection moves
1h
—
1d
+2.7%
3d
+0.3%
7d
-15%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS